GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Days Sales Outstanding

Genix Pharmaceuticals (TSXV:GENX) Days Sales Outstanding : 0.00 (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Days Sales Outstanding?

Genix Pharmaceuticals's average Accounts Receivable for the three months ended in Jan. 2024 was C$0.00 Mil. Genix Pharmaceuticals's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil.

The historical rank and industry rank for Genix Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

TSXV:GENX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.46   Med: 90.39   Max: 273.75
Current: 272.09

During the past 13 years, Genix Pharmaceuticals's highest Days Sales Outstanding was 273.75. The lowest was 39.46. And the median was 90.39.

TSXV:GENX's Days Sales Outstanding is ranked worse than
96.59% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs TSXV:GENX: 272.09

Genix Pharmaceuticals's Days Sales Outstanding declined from Jan. 2023 (593.13) to Jan. 2024 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Genix Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Genix Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Days Sales Outstanding Chart

Genix Pharmaceuticals Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 159.85 - - - 273.75

Genix Pharmaceuticals Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 593.13 136.88 425.83 - -

Competitive Comparison of Genix Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genix Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Days Sales Outstanding falls into.



Genix Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Genix Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Oct. 2023 is calculated as

Days Sales Outstanding (A: Oct. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Oct. 2022 ) + Accounts Receivable (A: Oct. 2023 )) / count ) / Revenue (A: Oct. 2023 )*Days in Period
=( (0.017 + 0.001) / 2 ) / 0.012*365
=0.009 / 0.012*365
=273.75

Genix Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

Days Sales Outstanding (Q: Jan. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Oct. 2023 ) + Accounts Receivable (A: Jan. 2024 )) / count ) / Revenue (A: Jan. 2024 )*Days in Period
=( (0.001 + 0.003) / 2 ) / 0*365 / 4
=0.002 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genix Pharmaceuticals  (TSXV:GENX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Genix Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Genix Pharmaceuticals (TSXV:GENX) Business Description

Traded in Other Exchanges
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. Some of its products are Renochlor, Sucanon, and Flu-X. The company primarily operates in Canada.
Executives
Sina Pirooz Director

Genix Pharmaceuticals (TSXV:GENX) Headlines

No Headlines